Pfam Domains GO Terms
| Proteasome |
| proteasome core complex, beta-subunit complex |
| proteasome core complex |
| threonine-type endopeptidase activity |
| proteasomal ubiquitin-independent protein catabolic process |
| proteasome complex |
| regulation of cellular amino acid metabolic process |
| regulation of hematopoietic stem cell differentiation |
| antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
| endopeptidase activity |
| regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| antigen processing and presentation of exogenous peptide antigen via MHC class I |
| regulation of cellular amine metabolic process |
| NIK/NF-kappaB signaling |
| anaphase-promoting complex-dependent catabolic process |
| regulation of hematopoietic progenitor cell differentiation |
| negative regulation of G2/M transition of mitotic cell cycle |
| SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| interleukin-1-mediated signaling pathway |
| Wnt signaling pathway, planar cell polarity pathway |
| antigen processing and presentation of peptide antigen via MHC class I |
| negative regulation of cell cycle G2/M phase transition |
| regulation of establishment of planar polarity |
| stimulatory C-type lectin receptor signaling pathway |
| innate immune response activating cell surface receptor signaling pathway |
| regulation of stem cell differentiation |
| tumor necrosis factor-mediated signaling pathway |
| regulation of transcription from RNA polymerase II promoter in response to stress |
| regulation of DNA-templated transcription in response to stress |
| non-canonical Wnt signaling pathway |
| positive regulation of canonical Wnt signaling pathway |
| regulation of cellular ketone metabolic process |
| Fc-epsilon receptor signaling pathway |
| negative regulation of canonical Wnt signaling pathway |
| cellular response to interleukin-1 |
| T cell receptor signaling pathway |
| positive regulation of Wnt signaling pathway |
| antigen processing and presentation of exogenous peptide antigen |
| regulation of mRNA stability |
| regulation of morphogenesis of an epithelium |
| antigen processing and presentation of exogenous antigen |
| regulation of RNA stability |
| cellular response to hypoxia |
| antigen processing and presentation of peptide antigen |
| regulation of G2/M transition of mitotic cell cycle |
| cellular response to decreased oxygen levels |
| response to interleukin-1 |
| regulation of mRNA catabolic process |
| negative regulation of Wnt signaling pathway |
| regulation of cell cycle G2/M phase transition |
| negative regulation of mitotic cell cycle phase transition |
| cellular response to oxygen levels |
| antigen processing and presentation |
| negative regulation of cell cycle phase transition |
| innate immune response-activating signal transduction |
| cellular response to tumor necrosis factor |
| Fc receptor signaling pathway |
| activation of innate immune response |
| regulation of animal organ morphogenesis |
| response to tumor necrosis factor |
| regulation of canonical Wnt signaling pathway |
| protein deubiquitination |
| antigen receptor-mediated signaling pathway |
| protein modification by small protein removal |
| protein polyubiquitination |
| negative regulation of mitotic cell cycle |
| proteasome-mediated ubiquitin-dependent protein catabolic process |
| negative regulation of cell cycle process |
| regulation of mRNA metabolic process |
| positive regulation of innate immune response |
| response to hypoxia |
| proteasomal protein catabolic process |
| cell-cell signaling by wnt |
| response to decreased oxygen levels |
| Wnt signaling pathway |
| regulation of Wnt signaling pathway |
| positive regulation of response to biotic stimulus |
| post-translational protein modification |
| MAPK cascade |
| response to oxygen levels |
| signal transduction by protein phosphorylation |
| regulation of mitotic cell cycle phase transition |
| cell surface receptor signaling pathway involved in cell-cell signaling |
| regulation of small molecule metabolic process |
| regulation of cell cycle phase transition |
| immune response-activating cell surface receptor signaling pathway |
| regulation of hemopoiesis |
| regulation of innate immune response |
| positive regulation of defense response |
| immune response-regulating cell surface receptor signaling pathway |
| positive regulation of multi-organism process |
| regulation of response to biotic stimulus |
| posttranscriptional regulation of gene expression |
| ubiquitin-dependent protein catabolic process |
| modification-dependent protein catabolic process |
| modification-dependent macromolecule catabolic process |
| immune response-activating signal transduction |
| negative regulation of cell cycle |
| proteolysis involved in cellular protein catabolic process |
| immune response-regulating signaling pathway |
| positive regulation of response to external stimulus |
| cellular protein catabolic process |
| activation of immune response |
| regulation of mitotic cell cycle |
| cytokine-mediated signaling pathway |
| protein catabolic process |
| protein ubiquitination |
| viral process |
| regulation of cell cycle process |
| regulation of defense response |
| protein modification by small protein conjugation |
| regulation of multi-organism process |
| symbiotic process |
| interspecies interaction between organisms |
| regulation of cellular catabolic process |
| positive regulation of immune response |
| cellular macromolecule catabolic process |
| response to organic cyclic compound |
| protein phosphorylation |
| protein modification by small protein conjugation or removal |
| regulation of catabolic process |
| response to organonitrogen compound |
| cellular response to cytokine stimulus |
| macromolecule catabolic process |
| regulation of anatomical structure morphogenesis |
| organonitrogen compound catabolic process |
| response to nitrogen compound |
| regulation of response to external stimulus |
| response to cytokine |
| cell-cell signaling |
| positive regulation of immune system process |
| regulation of immune response |
| response to abiotic stimulus |
| regulation of cell cycle |
| negative regulation of signal transduction |
| proteolysis |
| transmembrane transport |
| phosphorylation |
| negative regulation of cell communication |
| negative regulation of signaling |
| regulation of response to stress |
| negative regulation of response to stimulus |
| regulation of immune system process |
| positive regulation of signal transduction |
| intracellular signal transduction |
| cellular response to stress |
| organic substance catabolic process |
| cellular catabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| membrane |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| TCEB3C | 0.618 |
| TCEB3CL2 | 0.609 |
| TCEB3CL | 0.601 |
| RRP7A | 0.585 |
| PSMB4 | 0.58 |
| PRIM1 | 0.577 |
| COPG1 | 0.567 |
| DNTTIP2 | 0.563 |
| PSMA6 | 0.554 |
| RPL35 | 0.552 |
| POLE | 0.548 |
| GOLGA6L4 | 0.544 |
| CBWD3 | 0.543 |
| PSMB1 | 0.54 |
| GOLGA6L3 | 0.539 |
| TYMS | 0.538 |
| UTP20 | 0.534 |
| PSMD3 | 0.532 |
| TBC1D3F | 0.532 |
| RPS2 | 0.53 |
| MED17 | 0.524 |
| TBC1D3H | 0.522 |
| AQR | 0.521 |
| EXOSC9 | 0.518 |
| C14orf93 | 0.518 |
| INTS5 | 0.517 |
| SLC4A1 | 0.517 |
| TBC1D3 | 0.516 |
| PSMA7 | 0.515 |
| CHAF1A | 0.514 |
| LRR1 | 0.511 |
| CBWD5 | 0.511 |
| TBC1D3G | 0.51 |
| MT1E | 0.51 |
| VASN | 0.509 |
| NUPL1 | 0.505 |
| PSMD2 | 0.505 |
| NPIPB5 | 0.505 |
| WDR75 | 0.504 |
| CHD4 | 0.501 |
| CBWD6 | 0.501 |
| PSMD6 | 0.501 |
| DTL | 0.5 |
| ATP13A1 | 0.5 |
| PDE4DIP | 0.499 |
| RPS5 | 0.499 |
| UPF1 | 0.497 |
| PSMD14 | 0.495 |
| SLC6A17 | 0.494 |
| TWISTNB | 0.494 |
| ATP6V0B | 0.493 |
| UTP3 | 0.492 |
| PSMC5 | 0.492 |
| COL2A1 | 0.492 |
| RPS12 | 0.491 |
| PWP2 | 0.49 |
| COPE | 0.49 |
| BYSL | 0.488 |
| PSMC2 | 0.488 |
| C1QTNF9B | 0.486 |
| RRN3 | 0.486 |
| SH3BP1 | 0.484 |
| SUPT5H | 0.484 |
| AATF | 0.484 |
| CACTIN | 0.483 |
| NUP160 | 0.481 |
| CCNA2 | 0.479 |
| RPS7 | 0.479 |
| KRT78 | 0.479 |
| MYO18A | 0.479 |
| ZNF830 | 0.479 |
| CLN6 | 0.477 |
| KCTD17 | 0.477 |
| ATP6V1C1 | 0.477 |
| TICRR | 0.476 |
| POLR2J3 | 0.476 |
| SF3A3 | 0.476 |
| PHF2 | 0.475 |
| PSMD11 | 0.474 |
| TP53TG3C | 0.472 |
| TP53TG3 | 0.472 |
| TP53TG3B | 0.472 |
| MYB | 0.471 |
| TRAIP | 0.47 |
| SLC38A7 | 0.47 |
| EXOSC5 | 0.469 |
| XAB2 | 0.469 |
| COX7A2L | 0.469 |
| ATP6V1A | 0.468 |
| ORC1 | 0.467 |
| VPS28 | 0.467 |
| POLR1A | 0.467 |
| TSPY1 | 0.466 |
| PSMC6 | 0.466 |
| PDCD11 | 0.465 |
| TBC1D3I | 0.464 |
| TBC1D3E | 0.464 |
| TBC1D3L | 0.463 |
| POLR2F | 0.463 |
| COPB2 | 0.463 |
| TBC1D3K | 0.463 |
| ISY1 | 0.463 |
| RAD21 | 0.461 |
| CDC45 | 0.461 |
| PLK1 | 0.461 |
| ORC6 | 0.461 |
| PSMB3 | 0.46 |
| HIST2H3C | 0.459 |
| HIST2H3A | 0.459 |
| TSG101 | 0.458 |
| IGFN1 | 0.458 |
| CDC73 | 0.457 |
| EXOSC6 | 0.457 |
| TSPY2 | 0.457 |
| TBC1D3C | 0.457 |
| TPX2 | 0.455 |
| AHCTF1 | 0.455 |
| SEC13 | 0.454 |
| DHX38 | 0.453 |
| POLR2D | 0.453 |
| SNRPA1 | 0.453 |
| PAN2 | 0.452 |
| PSMA1 | 0.452 |
| POLA1 | 0.451 |
| DDTL | 0.451 |
| EIF4A3 | 0.451 |
| RANBP2 | 0.45 |
| RANGAP1 | 0.45 |
| CGB2 | 0.449 |
| SEL1L | 0.449 |
| FCN2 | 0.449 |
| PIGS | 0.449 |
| TUBA8 | 0.449 |
| ZFAND5 | 0.449 |
| MTCH2 | 0.449 |
| CEP192 | 0.448 |
| AAMP | 0.448 |
| NUP85 | 0.448 |
| EXOSC3 | 0.448 |
| RRP15 | 0.448 |
| PPFIA4 | 0.447 |
| PSMD1 | 0.447 |
| PLA2G4F | 0.447 |
| NUP54 | 0.446 |
| COPB1 | 0.445 |
| NELFCD | 0.445 |
| LAD1 | 0.444 |
| TP53TG3D | 0.444 |
| FBXW9 | 0.443 |
| ATP6V1B2 | 0.443 |
| AKT1S1 | 0.443 |
| CHMP2A | 0.443 |
| CGB1 | 0.441 |
| EBNA1BP2 | 0.439 |
| PAN3 | 0.439 |
| CDC6 | 0.439 |
| IK | 0.439 |
| SKIV2L2 | 0.438 |
| NBPF10 | 0.438 |
| MFSD12 | 0.438 |
| RPS19 | 0.437 |
| PRPF3 | 0.437 |
| POLR2L | 0.437 |
| SART1 | 0.436 |
| CKAP5 | 0.436 |
| POLR2A | 0.436 |
| C2orf27B | 0.435 |
| DIMT1 | 0.435 |
| RPS3 | 0.434 |
| AKIRIN2 | 0.434 |
| PSAP | 0.434 |
| PSMC1 | 0.434 |
| NAPA | 0.433 |
| POLR2H | 0.433 |
| RPS9 | 0.432 |
| FTSJ3 | 0.432 |
| MED14 | 0.432 |
| NFATC4 | 0.431 |
| GAR1 | 0.431 |
| OSBP | 0.431 |
| NSF | 0.431 |
| ATP6AP1 | 0.43 |
| COPA | 0.43 |
| BRD2 | 0.43 |
| PSMD7 | 0.43 |
| KRT2 | 0.43 |
| PAF1 | 0.429 |
| POLA2 | 0.428 |
| WDR43 | 0.428 |
| NOL10 | 0.428 |
| CHCHD3 | 0.428 |
| ACSF2 | 0.428 |
| POLD1 | 0.427 |
| DDT | 0.427 |
| CDH24 | 0.427 |
| NARFL | 0.426 |
| MCOLN1 | 0.426 |
| SULT1A4 | 0.425 |
| ARCN1 | 0.425 |
| SULT1A3 | 0.425 |
| SRRT | 0.425 |
| ART5 | 0.424 |
| DDX21 | 0.424 |
| CDCA3 | 0.423 |
| RUVBL2 | 0.423 |
| ACD | 0.423 |
| DDX47 | 0.422 |
| FAM25B | 0.422 |
| TFIP11 | 0.421 |
| HIVEP3 | 0.42 |
| CCDC116 | 0.42 |
| NUP62 | 0.419 |
| SMG1 | 0.419 |
| APC2 | 0.418 |
| MDM2 | 0.418 |
| TIMELESS | 0.417 |
| TONSL | 0.417 |
| NPIPB8 | 0.417 |
| NUP153 | 0.417 |
| ITGAX | 0.417 |
| BRIX1 | 0.416 |
| GOLGA6A | 0.415 |
| RNF113A | 0.415 |
| DDX56 | 0.415 |
| MYH7B | 0.415 |
| EGR2 | 0.415 |
| RPS3A | 0.415 |
| PRPF8 | 0.414 |
| FAM160A1 | 0.413 |
| GOLGA8O | 0.411 |
| GRAMD1A | 0.411 |
| RAD51 | 0.411 |
| PPIE | 0.411 |
| PLEKHA4 | 0.411 |
| PSMA5 | 0.411 |
| VPS51 | 0.41 |
| MPHOSPH10 | 0.41 |
| RPS11 | 0.41 |
| CCDC64B | 0.41 |
| KIAA0947 | 0.409 |
| MYO1H | 0.409 |
| NUP98 | 0.409 |
| WDR87 | 0.408 |
| RPS19BP1 | 0.408 |
| RIOK2 | 0.408 |
| ZNF219 | 0.408 |
| PLXNB3 | 0.408 |
| CTAGE4 | 0.408 |
| ATP6V0C | 0.408 |
| GOLGA8J | 0.407 |
| ANKLE2 | 0.407 |
| SF3A1 | 0.407 |
| FAM231C | 0.407 |
| FAM231A | 0.407 |
| VPS52 | 0.406 |
| RPL34 | 0.406 |
| RPS28 | 0.406 |
| PBXIP1 | 0.405 |
| SYT9 | 0.405 |
| FBL | 0.405 |
| C3orf17 | 0.404 |
| SUPT6H | 0.404 |
| MYLK3 | 0.404 |
| CWC22 | 0.403 |
| GPX4 | 0.403 |
| IL2RB | 0.403 |
| CDCA5 | 0.403 |
| PNO1 | 0.403 |
| GOLGA6L1 | 0.402 |
| TAF1 | 0.402 |
| KPNB1 | 0.401 |
| NGDN | 0.401 |
| RNPC3 | 0.401 |
| POP7 | 0.401 |
| EXOSC8 | 0.401 |
| CRNKL1 | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 27/28 |
| blood | 28/28 |
| bone | 20/26 |
| breast | 33/33 |
| central nervous system | 53/56 |
| cervix | 4/4 |
| colorectal | 15/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 16/16 |
| kidney | 20/21 |
| liver | 16/20 |
| lung | 71/75 |
| lymphocyte | 15/16 |
| ovary | 26/26 |
| pancreas | 21/24 |
| peripheral nervous system | 16/16 |
| plasma cell | 14/15 |
| prostate | 1/1 |
| skin | 18/24 |
| soft tissue | 8/9 |
| thyroid | 2/2 |
| upper aerodigestive | 21/22 |
| urinary tract | 26/29 |
| uterus | 4/5 |
Expression Distribution